LeadStory

Health



BREAKINGGLOBALUS approves two gene therapies for sickle cell disease

US approves two gene therapies for sickle cell disease

The U.S. Food and Drug Administration (FDA) on Friday approved two gene therapies for sickle cell disease, making one of them the first treatment in the United States based on the Nobel Prize-winning CRISPR gene editing technology.

Al Jazeera
Al Jazeera